Kyoto Drug Discovery & Development is Drug Discovery in Japan that focus on retinitis pigmentosa business. Founded in 2015. They cover business area such as developer, therapeutic drug, chronic degenerative disease, diagnosis, central retinal artery occlusion, retinitis pigmentosa, intractable eye disease, doctor, patient.
2015
( 9 years old in 2024 )
Retinitis Pigmentosa
-
36-1 Yoshida-Honmachi, Sakyo-ku
University International Science and Innovation Building, Kyoto University
Kyoto, 606-8501
Japan
Private
developertherapeutic drugchronic degenerative diseasediagnosiscentral retinal artery occlusionretinitis pigmentosaintractable eye diseasedoctorpatient
* We use standard office opening hours in near Kyoto Drug Discovery & Development's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kyoto Drug Discovery & Development is Drug Discovery business from Japan that founded in 2015 (9 years old in 2024), Kyoto Drug Discovery & Development business is focusing on Retinitis Pigmentosa.
Kyoto Drug Discovery & Development headquarter office and corporate office address is located in 36-1 Yoshida-Honmachi, Sakyo-ku University International Science and Innovation Building, Kyoto University Kyoto, 606-8501 Japan.
Kyoto Drug Discovery & Development was founded in Japan.
In 2024, Kyoto Drug Discovery & Development is currently focus on retinitis pigmentosa sector.
Above is snippet of Google Trends for "retinitis pigmentosa" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kyoto Drug Discovery & Development, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
